Report Materials
The objective of this audit was to assess whether additional benefits proposed in NYLCare's Contract Year (CY) 2000 adjusted community rate proposal (ACRP) were available to Medicare beneficiaries at reasonable costs and as advertised, and that these benefits were both credible and properly valued. We found that, during 2000, NYLCare provided additional benefits as proposed in its CY 2000 ACRP and as advertised in its marketing brochures. We also found that NYLCare provided prescription drugs to Medicare enrollees at reduced rates by taking advantage of discounts negotiated with independent pharmacies that dispensed the prescription drugs. However, our review disclosed problems with the prescription drug benefit component on NYLCare's CY 2000 ACRP that impacted both the Medicare beneficiaries enrolled in the plan, as well as NYLCare itself.
Notice
This report may be subject to section 5274 of the National Defense Authorization Act Fiscal Year 2023, 117 Pub. L. 263.